Colace and Ultravist drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Colace (docusate ) and Ultravist (iopromide). Common drug interactions include acute circulatory failure among females and nephrogenic systemic fibrosis among males.
The phase IV clinical study analyzes what interactions people have when they take Colace and Ultravist. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.
What is Colace?
Colace has active ingredients of docusate . It is often used in constipation. eHealthMe is studying from 41,841 Colace users. Check the latest studies of Colace.
What is Ultravist?
Ultravist has active ingredients of iopromide. eHealthMe is studying from 9,246 Ultravist users. Check the latest studies of Ultravist.
12 people who take Colace and Ultravist together, and have interactions are studied.

What are the common drug interactions of Colace and Ultravist, by gender? *:
female:
- Acute circulatory failure (shock)
- Electrocardiogram st segment elevation
- Hypotension (abnormally low blood pressure)
- Hypoventilation (too shallow or too slow breathing, which does not meet the needs of the body)
- Lethargy (tiredness)
- Pain in limb
- Pulse absent
- Sinus bradycardia (an unusually slow heartbeat due to heart disease)
- Speech disorder
- Urticaria (rash of round, red welts on the skin that itch intensely)
male:
- Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
- Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
- Scar
- Skin hyperpigmentation (disorders affect the colour of your skin)
- Arthralgia (joint pain)
- Deformity (disfigurement)
- Fatigue (feeling of tiredness)
- Mobility decreased (ability to move is reduced)
- Myalgia (muscle pain)
- Ocular icterus (presence of jaundice seen in the sclera of the eye)
What are the common drug interactions of Colace and Ultravist, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Nausea (feeling of having an urge to vomit)
- Vomiting
30-39:
- Anxiety
- Arthralgia (joint pain)
- Deformity (disfigurement)
- Emotional distress
- Fatigue (feeling of tiredness)
- General physical health deterioration (weak health status)
- Joint contracture (a permanent shortening of a muscle or joint)
- Mobility decreased (ability to move is reduced)
- Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
- Myalgia (muscle pain)
40-49:
- Joint contracture (a permanent shortening of a muscle or joint)
- Joint range of motion decreased (disease of joint movement)
- Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
- Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
- Oedema peripheral (superficial swelling)
- Skin hypertrophy (skin cells enlarges)
- Skin induration (an abnormally hard spot or area on the skin)
- Skin tightness
50-59:
- Urticaria (rash of round, red welts on the skin that itch intensely)
60+:
- Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
- Pain
- Hypoaesthesia (reduced sense of touch or sensation)
- Hypotension (abnormally low blood pressure)
- Hypoventilation (too shallow or too slow breathing, which does not meet the needs of the body)
- Injury
- Lethargy (tiredness)
- Muscular weakness (muscle weakness)
- Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
- Oedema peripheral (superficial swelling)
What are the existing conditions these people have? *
- Computerised Tomogram Abdomen: 3 people, 25.00%
- Phosphorus Metabolism Disorder: 2 people, 16.67%
- Oedema (fluid collection in tissue): 2 people, 16.67%
- High Blood Pressure: 2 people, 16.67%
- Diabetes: 2 people, 16.67%
- Depression: 2 people, 16.67%
- Blood Phosphorus Abnormal: 2 people, 16.67%
- Bleeding Disorders: 2 people, 16.67%
- Anaemia Of Chronic Disease: 2 people, 16.67%
- Hypoparathyroidism (inadequate secretion of parathyroid hormone resulting in abnormally low levels of calcium in the blood): 1 person, 8.33%
* Approximation only. Some reports may have incomplete information.
Do you take Colace and Ultravist?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Colace and Ultravist:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Colace:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Ultravist:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Colace and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ultravist and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on docusate and iopromide (the active ingredients of Colace and Ultravist, respectively), and Colace and Ultravist (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Rapaflo and Protonix - 11 seconds ago
- Drug interactions of Ibuprofen and Calcium Citrate - 13 seconds ago
- Could Fosaprepitant Dimeglumine cause Fatigue? - 18 seconds ago
- Could Leucovorin Calcium cause Portal Hypertension? - 22 seconds ago
- Could Vitamin B12 cause Intervertebral Disc Space Narrowing? - 26 seconds ago
- Could Visudyne cause Ocular Vascular Disorder? - 35 seconds ago
- Drug interactions of Magnesium Sulfate and Botox - 37 seconds ago
- Non-Hodgkin'S Lymphoma Stage Iii and Bone Density Decreased - 42 seconds ago
- Could Pentasa cause Consciousness - Decreased? - 45 seconds ago
- Drug interactions of Benadryl and Nasacort Aq - 56 seconds ago